Fortitude Family Office’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.74K Buy
85
+12
+16% +$275 ﹤0.01% 1530
2026
Q1
$1.61K Buy
73
+28
+62% +$487 ﹤0.01% 1359
2025
Q4
$531 Hold
45
– – ﹤0.01% 1686
2025
Q3
$713 Sell
45
-45
-50% -$653 ﹤0.01% 1666
2025
Q2
$1.03K Sell
90
-580
-87% -$6.54K ﹤0.01% 1487
2025
Q1
$9.06K Hold
670
– – ﹤0.01% 564
2024
Q4
$11.3K Buy
+670
New +$13K ﹤0.01% 596
2024
Q3
– Sell
-10
Closed -$226 – 1218
2024
Q2
$226 Sell
10
-149
-94% -$3.9K ﹤0.01% 939
2024
Q1
$4.17K Hold
159
– – ﹤0.01% 680
2023
Q4
$5.01K Buy
+159
New +$4.32K ﹤0.01% 633

Other funds holding CC

Fortitude Family Office's CC Position: Q2 2026 in Review

Fortitude Family Office increased its Chemours (CC) stake by 16% in Q2 2026, buying an estimated $275 and bringing the position to 85 shares worth $1.74K. The position accounts for ﹤0.01% of the portfolio, ranked #1530.

Fortitude Family Office first reported a position in CC in Q4 2023 and has held it in 10 quarters since. The position peaked at $11.3K in Q4 2024. 474 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • Fortitude Family Office held 85 shares of Chemours worth $1.74K as of Q2 2026.
  • Fortitude Family Office bought 12 Chemours shares in Q2 2026, an estimated $275.
  • Chemours made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #1530 holding.
  • Fortitude Family Office first reported a position in Chemours in Q4 2023 and has held it in 10 quarters since.
  • Fortitude Family Office's Chemours position peaked at $11.3K in Q4 2024.
  • 474 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.